Testing a new sugar-bead treatment for weight loss in obesity
Part of Hormones & metabolism clinical trials.
This study tests a new treatment—small beads of sugar that release in the lower intestine—to help people with obesity and related health conditions lose weight. It compares two different doses of the beads plus a gel to a placebo (inactive treatment).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You need to have a body mass index (BMI) of 30 or higher, or a BMI of 27 to 30 with at least one weight-related health issue like high blood pressure, high cholesterol, heart disease, or sleep apnea.
- Your weight should have been stable (within 5%) for the past 3 months.
- You must have tried to lose weight through dieting before but not been successful long-term.
- You must be fully vaccinated against COVID-19 (all recommended doses of a recognized vaccine, or recovered from COVID-19 plus at least one vaccine dose).
- You cannot have had weight-loss surgery or certain stomach procedures, or have certain medical conditions like severe kidney disease, heart problems, or active pancreatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
This study tests two investigational medications, MET233 and MET097, in people with obesity or overweight, with or without type 2 diabetes. It aims to see if the combination can help with weight loss and blood sugar control.
This trial tests a new injectable medication called SHR-1179 to see if it is safe and can help with weight loss. It is a placebo-controlled study, meaning some participants receive the drug and others receive an inactive shot, and no one knows which they get.
This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This study tests an investigational medicine for weight loss in people with excess weight. It aims to see how effective the medicine is and may help you lose weight and improve health.
Hear when a new Obese Patients (BMI ≥ 30 kg/m²) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.